Search

Your search keyword '"Reich, Adam"' showing total 1,401 results

Search Constraints

Start Over You searched for: Author "Reich, Adam" Remove constraint Author: "Reich, Adam"
1,401 results on '"Reich, Adam"'

Search Results

102. Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries

103. Psoriasis

105. Clinical and epidemiological analysis of basosquamous carcinoma: results of the multicenter study

107. From Hard Labor to Market Discipline: The Political Economy of Prison Work, 1974 to 2022.

108. Polish guidelines for the diagnosis and treatment of hidradenitis suppurativa.

109. White paper on psychodermatology in Europe: A position paper from the EADV Psychodermatology Task Force and the European Society for Dermatology and Psychiatry (ESDaP).

110. IFSI-guideline on chronic prurigo including prurigo nodularis

111. Pruritus

114. Skin Microbiome in Prurigo Nodularis

115. How does a chronic wound change a patient's social life? A European survey on social support and social participation

119. Chłoniaki pierwotne skóry. Rekomendacje diagnostyczno-terapeutyczne Polskiego Towarzystwa Dermatologicznego (PTD) i Polskiej Grupy Badawczej Chłoniaków (PLRG).

121. Chronic prurigo: Insufficient disease control in spite of high healthcare usage

122. Risankizumab Therapy for Moderate-to-Severe Psoriasis—A Multi-Center, Long-Term, Real-Life Study from Poland

123. Skin pain: A symptom to be investigated

124. 353 Amlitelimab reduces serum IL-13 in a phase 2a clinical trial in atopic dermatitis without impacting T-cell expansion in a T-cell recall assay

125. 345 Treatment with amlitelimab—a novel non-depleting, non-cytotoxic anti-OX40Ligand monoclonal antibody—reduces IL-22 serum levels in a phase 2a randomized, placebo-controlled trial in patients with moderate-to-severe atopic dermatitis

127. Characteristics of pruritus in various clinical variants of psoriasis: Final report of the binational, multicentre, cross‐sectional study

128. Primary cutaneous lymphomas. Diagnostic and therapeutic guidelines of the Polish Dermatological Society (PTD) and Polish Lymphoma Research Group (PLRG)

130. A novel, fixed‐dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 th EADV Congress 2021

132. Workers' Health On the Line: A Digital Intervention to Address the Fundamental Causes of Disease in the Low-Wage Retail Sector

133. Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021

135. Inherited ichthyoses patients: Individualized care and support urgently needed.

140. The Impact of Pruritus on the Quality of Life and Sleep Disturbances in Patients Suffering from Different Clinical Variants of Psoriasis

144. 33781 Sustained and durable response up to 24 weeks after last dose observed in a phase 2a study (NCT03754309) of amlitelimab (KY1005, SAR445229) a novel nondepleting anti-OX40Ligand (OX40L) mAb in patients with moderate to severe atopic dermatitis (AD)

147. Drugs

Catalog

Books, media, physical & digital resources